## 

## 



## 

## 

## 

|Contents|Page|
|---|---|
|Report ofthe Management<br>Committee|1-18|
|Independent<br>Auditors'<br>report|19-22|
|Statement<br>of Financial Activities|23-24|
|Balance Sheet|25|
|Cash Flow Statement|26|
|Notes to the financial statements|27-47|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

|Donations<br>and|Legacies|Legacies||||f2,815,346|82,950,528|
|---|---|---|---|---|---|---|---|
|Other Tradin|Activities|||||F133,617|5793,140|
|Investments||||||F53,646|660,692|
|Other income||||||6125,215|60|
|Charitable<br>Activities||||||F862,979|f864,971|
|Raising Funds||||||F1,020,125|F1,278,033|
|Other||||||611,962|611,720|
|Net Gain I(Loss) on||Investments||||F130,638|(F128,335)|
|le%<br>egJ"||e|ttirs Ãf&eaV|=—".'|' .-.|~:SA&3|',; ='.R4<br>Ft'4l|
|Funds camed|forward|from prior year||||F7,641,903|66,120,602|
|Build a Better|Future|Capital|Appeal cern'ed fonwrd|||Z6, 107,779|F4,992,590|
|Other funds camed foruerd||||||82,897,520|E2,649313|



## 



## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

|The assets and liabilities|ofour charity as at 31st Mar|ch 2021 are stated below:||
|---|---|---|---|
||||RO'tel|
|Fixed Assets||f2,828,116|E2,692,450|
|Net Current Assets||E6,504,994|F5,163,272|
|Non Current<br>Liabilities<br>TIE'Ivl:<br>WSL' ',,-||(f327,811)|(E213,819)|
|Unrestricted<br>Undesignated|Income Funds|E1,007,330|f384,695|
|Unrestricted<br>Designated|Income Funds|F4,738,686|E4,098,558|
|Restricted<br>Income Funds||f3,245,984|f3,036,090|
|Pro(it Retained<br>in Subsidiary<br>||E13,299|f122,560|




## 

## 



## 

## 

## 

|Total|Unrestricted|Funds of||||5,759,315||4,605,813|
|---|---|---|---|---|---|---|---|---|
|Less:|Designated|Funds of|5|||4,738,686|5|4,098,558|
|Less:|Fixed Assets of||E|||576,508||613,345|
||||:0.|''|"|'444,421 I|'4'|'100,090,|





## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 



## 



## 

## 

||||||Unrestricted|Restricted|31 March|31 March|
|---|---|---|---|---|---|---|---|---|
|||||Note|Funds|Funds|2021|2020|
||||||6|6|f||
|Income and endowments|||from||||||
|- Donations<br>and|Legacies|||3|2,378,354|436,992|2,815,346|2,950,528|
|-Other trading actiuties||||3|133,617||133,617|793,140|
|- investments||||2, 3|53,646||53,646|60,692|
|-Other||||3|125,215||125,215||
|Total|||||2,690,832|436992|3 127824|3804360|
|Expenditure<br>on|||||||||
|- Raising Funds||||2, 4, 5|1,020,125||1,020,125|1,278,033|
|- Charitable<br>activities||||4|635,881|227,098|862,979|864,971|
|- Other||||4|11,962||11,962|11,720|
|Total|||||1,667,968|227,098|1,895,066|2, 154,724|
|Net gains/(losses)||on inu.stments||11|130,638||130,638|(128,335)|
|Net income|||||1,153,502|209,894|1,363,396|1,521,301|
|Transfers<br>between||funds|||||||
|Net movement|in|funds|||1,153,502|209,894|1,363,396|1,521,301|
|Reconciliation<br>of||funds|||||||
|Total funds<br>brought||forward||17, 18|4,605,813|3,036,090|7,641,903|6,120,602|
|Total funds carried forward|||||5,?59,315|3,245,984|9,005,299|7,641,903|





## 

## 

|||||Unrestrtcted|Restricted|31 March|31March|
|---|---|---|---|---|---|---|---|
||||Note|Funds|Funds|2021|2020|
|||||6|6|f|6|
|income and endowments||from:||||||
|- Donations<br>and Legacies||||2,378,354|436,992|2,815,346|2,950,528|
|-Other trading<br>activities||||60,683||60,683|546,854|
|-Investments||||165,918||165,918|154,880|
|-Other||||125,215||125,215||
|Total income||||2,730,170|436,992|3,167,162|3,652,262|
|Expenditure<br>on:||||||||
|-Raising Funds|||4, 5|950,202||950,202|1,144,019|
|- Charitable<br>activities|||4|635,881|227,098|862,979|864,971|
|-Other|||4|11,962||11,962|11,720|
|Total resources expended||||1,598,045|227,098|1,825,143|2,020,710|
|Net gains/(losses)|on Investments||11|130,638||130,638|(128,335)|
|Net income||||1,262,763|209,894|1,472,657|1,503,217|
|Transfers<br>between|funds|||||||
|Net movement<br>in|funds|||1,262,763|209,894|1,472,657|1,503,217|
|Reconciliation<br>of|funds|||||||
|Total funds<br>brought|forward||17, 18|4,483,253|3,036,090|7,519,343|6,016,126|
|Total funds carried forward||||5,746,016|3,245,984|8,992,000|7,519,343|





## 

## 

||||The Group||The|Charity|
|---|---|---|---|---|---|---|
||||31 March|31 March|31 Nlarch|31 March|
|||Note|2021f|2020f|2021f|2020f|
|Fixed assets|||||||
|Intangible assets||9|91,461|103,798|91,461|103,798|
|Tangible assets||10|485,047|509,547|485,047|509,547|
|Investments||11|2,251,608|2,079,105|2,254,608|2,082,105|
|Total fixed assets|||2,828,116|2,692,450|2,831,116|2,695,450|
|Current Assets|||||||
|Stocks||2, 13|61,209|38,524|||
|Debtors||2, 12|1,452,334|1,921,269|1,157,759|1,649,017|
|Cash at bank and|in hand||6,710,930|4,099,766|6,652,194|3,981,459|
|Total current assets|||8,224,473|6,059,559|7,809,953|5,630,476|
|Liabilities|||||||
|Creditors<br>failing due within|||||||
|one year||2, 14|(1,719,479)|(896,287)|(1,321,258)|(806,583)|
|Net current assets|||6,504,994|5,163,272|6,488,695|4,823,893|
|one year||2, 15|(327,811)|(213,819)|(327,811)||
|Total net assets|or liabilities||9,005,299|7,641,903|8,992,000|7,519,343|
|The funds ofthe|charity||||||
|Unrestricted<br>income funds||17|5,759,315|4,605,813|5,746,016|4,483,253|
|Restricted income|funds|18|3,245,984|3,036,090|3,245,984|3,036,090|
|Total funds|||9,005,299|7,641,903|8,992,000|7,519,343|





## 

## 

||||31 March|31 March|31 INarch|31 March|31 March|
|---|---|---|---|---|---|---|---|
|||||2021<br>f|2021<br>f|2020f|2020f|
|Cash flows from operating<br>activities||||||||
|Net cash provided<br>by (used||in)||||||
|operating<br>activities|||||2,251,193||2,167,660|
|Cash flows from financing|activities:|||||||
|Loans received|||343,000|||||
|Repayment<br>of bank borrowings|||(4,618)|||||
|Interest paid|||(2,941)|||||
|Net cash provided<br>by (used||in)||||||
|gnancing<br>acgvitles|||||335,441|||
|Cash flows from investing|activities:|||||||
|Payments<br>to acquire tangible||lixed||||||
|assets||||||(515,862)||
|Purchase<br>ofinvestments|||(808,672)|||(424,028)||
|Sale ofinvestments|||756,301|||380,258||
|Investment<br>cash movement|||10,506|||(5,162)||
|Interest receivable|||16,315|||15,690||
|Dividends<br>receivable|||50,080|||52,180||
|Net cash provided<br>by (used <br>investing<br>activities||in)|||24,530||~444.424|
|Net increase<br>in cash snd cash||||||||
|equivalents|||||2,611,164||1,670,736|
|Cash and cash equivalents||at|1 April 2020||4,099,766||2,429,030|
|Cash and cash equivalents||st|31 INarch 2021||6,710,930||4,099,766|
|Cash and cash equivalents||consists of:||||||
|Cash at bank and in hand|||||6,710,930||4,099,766|
|Reconciliation<br>of net income to net cash flow||||from|operating<br>activities|||
||||||2021<br>f.||2020f|
|Net income forthe reporting||period (as per the||||||
|statement offinancial<br>activities)|||||1,363,396||1,521,301|
|Dividends<br>received|||||(50,080)||(52,180)|
|Interest receivable|||||(16,315)||(15,690)|
|Interest payable|||||2,941|||
|(Gains)/losses<br>on investments|||||(130.638)||128,335|
|(increase)/decrease<br>in stock|||||(22,685)||(21.463)|
|(Increase)/decrease<br>in debtors|||||468,935||548,798|
|Increase/(decrease)<br>in creditors|||||598,802||37,093|
|Depreciation<br>& amortisation|charge||||36,837||21,466|
|Net cash flow from operating|||activities||2,251,193||2,167,660|
|Analysts ofchanges net debt|||||2021f|Cash Flowsf|2020f|
|Cash at bank and in hand|||||6,710,930|2,701,164|4,099,766|
|Borrowln9s||||||||
|Bank borrowings<br>due within one|||year||(10,571)|(10,571)||
|Bank borrowings<br>due after one||year|||327,811|327,811||
|Total nst debt|||||6,372,548|2,362,782|4,099,766|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|Turnover|||2021f|2020<br>f|
|---|---|---|---|---|
|Cost ofsales|||72,934<br>~68.176|246,286<br>~132,893|
|Gross profit|||4,818|113,396|
|Administration<br>expenses|||(1,807)|(1,124)|
|Operating<br>Profit/(loss)|||3,011|112,272|
|Retained<br>profit/(loss)|for|the year|3,011|112,272|
|Retained<br>profits brought<br>forward<br>Giit Aid distribution<br>to Charity|||122,560<br>~112272|104,476<br>~94,488|
|Retained<br>profit/(loss)|carried forward||13,299|122,560|
|Net Assets|||13299|122,560|
|Current assets|||2021f|2020f|
|Stocks|||61,209|38,524|
|Debtors|||306,369|278,266|
|Cash in hand|||58,736|118,307|
||||426,314|435,097|
|Creditors<br>Amounts<br>falling due|within one year||~419915|~95,718|
|Net current assets|||16,299|339,379|
|Amounts<br>falling due|atter|more than one year||~213,819|
|Total net assets or|liabilities||16,299|125560|
|Capital and reserves|||||
|Called up share capital|||3,000|3,000|
|Retained<br>earnings|||13,299|122,560|
|Shareholder's<br>funds|||16,299|125,560|





## 

## 

## 

|Notes tothe financial stateme<br>3.Income|nts<br>forthe year e|nded 31INarch 2|021||
|---|---|---|---|---|
|Donations and legacies|Unrestricted<br>f|Resbfcted f|2021|2020|
|Donations<br>&giits|1,932,435|436,992|2,369,427|2,518,435|
|Legacies|445,919||445,919|432,093|
||2,378,354|436,992|2,815,340|2.950 528|
|Other trading activities|Unrestricted|Restricted f|2021<br>f|2020|
|Trading<br>Income|72,934||72,934|246,286|
|Fundraising<br>and ewnt income|60,683||60,683|546,854|
||133,617||133,617|793.14D|
||Unrestricted|Restricted|2021|2020|
|Invesbnent<br>income|f||f||
|Dividends|50,080||50,080|52,180|
|Interest|16,315||16,315|15,690|
|Gain on disposal|(12,749)||(12,749)|(7,178)|
|Gift Aid from Theo Bear Trading|112,272||112,272|94,188|
|Company<br>Limited|||||
||165,918||165,918|154,88D|
|Other Income|Unrestricted|Resb ictedf|2021f|2020f|
|COVID Job Retention Scheme|125,215||125,215||
||125215||125,215||
|4.Expenditure<br>on raising funds|Unrestrictedf|Reslrlctedf|2021|2020f|
|Costs ofraising donations|938,971||938,971|971,263|
|Trading company costs<br>Eat costs|69,923<br>11,231||69,923<br>11,231|134,014<br>172,756|
|inu:stment<br>related expenditure|11,962||11,962|11,720|
||1,032,087||1,032087|1,209753|
|Charitable<br>activities|Grant Fundingf|Supportf|2021f|2020|
|Designated<br>Fund Grants|623,023||623,023|706,720|
|Restricted<br>Fund Grants|81,771||81,771|46,582|
|Research: allocations|160,214||160,214|98,864|
|Research: written back|(34,185)||(34,185)|(12,332)|
|Support Costs||32,156|32,156|25,137|
||830,823|32,156|862,979|864,971|





## 

## 

## 

## 

|5.Resources expended|5.Resources expended|2021f|2020f|
|---|---|---|---|
|Allocation|ofsupport costs|||
|Governance||5,121|2,458|
|Information|Technology|6,740|3,667|
|Human<br>Resources||5,393|3,604|
|Oflice Costs||9,385|9,931|
|Other||5,517|5,477|
|||32,155|25,137|
|The basis|ofallocation is staff time spent.|||
|Governance<br>costs||2021f|2020|
|Auditor's<br>remuneration||8,400|5,952|
|Legal fees||6,273||
|Other||13,775|9,411|
|||28,448|15,363|



## 



## 

## 

## 

## 

|7.Staff costs|2021|2020|
|---|---|---|
||6||
|Basic salary|624,211|645,710|
|Social Security costs|53,194|53,377|
|Pension costs|42,565|48,536|
||719,970|747,623|



|||||2021|2020|
|---|---|---|---|---|---|
|Cost ofraising||voluntan/|income|18|21|
|Charitable|activities|||4|4|
||||||25|



## 



## 

## 

## 

## 

|Notes tothe financial statements<br>for the yea<br>9.Intangible<br>assets|r ended 31March 20|
|---|---|
|Cost||
|At 1 April 2020|128,146|
|Additions||
|At 31 March 2021|128,146|
|Amortisation||
|At 1 April 2020|24,348|
|Amortisation<br>in year|12,337|
|At 31 March 2021|36,685|
|Net book value at 31 March 2021|91,461|
|Net book value at 31 March 2020|103798|



## 

|10.Tangible|fixed assets||||
|---|---|---|---|---|
|||Charity and|Charity||
|||Group Office|and Group||
|||Equipment|Buildings|Total|
|||6|K|6|
|Cost|||||
|At 1 April 2020||58,782|495,343|554,125|
|Additions|||||
|At 31 March|2021|58,782|495,343|554,125|
|Depreciation|||||
|At 1 April 2020||39,625|4,953|44,578|
|Depreciation|in year|4,686|19,814|24,500|
|At 31 March|2021|44,311|24,767|69,078|
|Net book value at 31 March 2021||14,471|470,576|485,047|
|Net book uslue at 31 March 2020||19,157|490,390|509,547|





## 

## 

## 

## 

|11.Fixed asset investment|11.Fixed asset investment|11.Fixed asset investment||Listed|Other||
|---|---|---|---|---|---|---|
|||||Invesbnents|investments|Total|
|Cost or valuation|||||||
|At 1 April 2020||||2,079,105|3,000|2,082,105|
|Additions||||808,672||808,672|
|Disposals||||(756,301)||(756,301)|
|Movement<br>in cash held||||(10,506)||(10,506)|
|Revaluation<br>gain/(loss)||||130,638||130,638|
|At 31 March 2021||||2,251,608|3,000|2,254,608|
|Carrying<br>amount at|31March 2021|||2,251,608|3,000|2,254,608|
|investments<br>at fair value||(determined|by reference||2021|2020|
|to the quoted<br>market|value at the balance sheet||||||
|date) compromises:|||||||
|The Charity|||||||
|Shams<br>in subsidiary|undertaking||||3,000|3,000|
|Equities<br>/ Bond Funds|||||2,000,498|1,318,224|
|Securities|||||239,568|738,833|
|Cash within<br>investment||portfolio|||11,542|22,048|
|Total|||||2,255,608|2,082,105|





## 

## 

## 

|12.Debtors|||The Group||The|Charity|
|---|---|---|---|---|---|---|
||||31 March|31 March|31March|31 March|
||||2021f|2020f|2021f|2020f|
|Amounts<br>due within the year|||||||
|Trade Debtors|||100,272|158,583|||
|Prepayments<br>-Amounts|and <br>due(|accrued income<br> 1 year|1,352,062|1,080,503|1,145,965|1,080,503|
|-Amounts|due)|1 year||682,183||562,500|
|Amounts<br>owed by||group undertakings|||11,794|6,014|
||||1,452,334|1,921,269|1.157,759|1.649,617|



|13.Stock|The Group||The|Charity||
|---|---|---|---|---|---|
||31 March|31March|31 March|31|March|
||2021f|2020f|2021f||2,020f|
|Stock ofgoods for resale|61209|38524||||
||61,209|38,524||||





## 

## 

|14.Cre|d|itors: amo|unts falling due in le|ss than one year||||
|---|---|---|---|---|---|---|---|
|||||The Group||The|Charity|
|||||31March|31March|31March|31 March|
|||||2021|2020|2021|2020|
|||||||6|F|
|Trade Creditor||||861,044|174,837|809,662|131,678|
|Creditors,||accruals|and deferred income|435,196|297,190|109,969|296,190|
|Tax and||Social Security||35,289|62,267|13,677|16,722|
|Amounts||committed|to projects|377,379|361,993|377,379|361,993|
|Charity|bank loan|||10,571||10,571||
|Amounts||owed to group undertakings||||||
|||||1,719,479|896,287|1,321,258|81$58S|
|15.Credttortx<br>amounts falling due after||||more than one year||||
|||||The Group||The|Charity|
|||||31March|31March|31March|31 March|
|||||2021|2020|2021|2020|
|||||||F||
|Creditors,||accruals|and deferred income||213,819|||
|Charity|bank loan|||327,811||327,811||
|||||327 ~11|213813|327 811||



## 

## 



## 

## 

## 

|17.Unrestricted||funds||Balance|||||Balance|
|---|---|---|---|---|---|---|---|---|---|
|||||1 April|Incoming|Expenditure|&||31 March|
|||||||Grants||||
|||||2020|Resources|Committed||Transfers|2021|
|Designated:||||f||||||
|-A&E||||358,848|9,647||||368,495|
|-AAU||||879|||||879|
|-Action Lab||||4,627|83||||4,710|
|-Becton General|||||6,365||||6,365|
|- Bereavement||||55,767|1,225|(4,628)|||52,364|
|-Bone Disease|Ol|||17,306|3,105||||20,411|
|-Burns<br>Unit||||33,044|1,915|(815)|||34,144|
|-Cardiac Care|||||25||||25|
|-Sophie's<br>Fund||||1,167|||||1,167|
|-Amber Lodge|~MHS|||2,124|||||2,124|
|- Emerald Lodge||-CAMHS||3,391|195||||3,586|
|- Ruby Lodge ~MHS||||2,194|||||2,194|
|-Sapphire<br>Lodge||-CAMHS||6,022||(180)|||5,842|
|-Classroom<br>&|Becton School|||5,339|||||5,339|
|-Community<br>CAHMS||||8,217|1,263||||9,480|
|-Comm Physio||||2,128|||||2,128|
|-Covid-19||||57,841|198,791|(41,505)|||215,127|
|-CWAHMSParentLiason||||1,976|||||1,976|
|-Cystic Fibrosis||Centre||30,159|624|(5,973)|||24,810|
|-Dermatology||||522|||||522|
|-Diabetes||||26,066|14,386|(48)|||40,404|
|-Embrace||||84,345|12,036|(11,104)|||85,277|
|-Endocrine clinic||||10,436|||||10,436|
|- ENT||||28,025|1,165||||29,190|
|-Eye Department||||6,777|11,201||||17,978|
|-Food Therapy||||8,253|||||8,253|
|-Gait Lab||||3|||||3|
|-Gastroenterology||||6,457|||||6,457|
|-Genetics||||6,365||(385)|||5,980|
|-Haematology|&|Oncology||768,703|565,296||||1,333,999|
|- Haematoiogy|8|Oncology|1718|||||||
|Pre launch||||45,423||(5,257)|||40,166|
|- Hearing Senices||||321|||||2,625|
|- Late Etiects||||36,264|||||36,264|
|- Leukaemia<br>8|Oncology Research|||69,442|1 069|(14,887|||55,624|
|Sub4otal||||1,688,431|830,695|(84,782)|||2,434,344|
|Continued<br>overteaf. ..||||||||||





## 

## 

|Notes tothe financial stateme|Notes tothe financial stateme|Notes tothe financial stateme|nts<br>for the y|ear ended|31March 2|021||||
|---|---|---|---|---|---|---|---|---|---|
|17.Unrestricted<br>funds||||||||||
|(continued. ..)|||Balance||||||Balance|
||||1 April|Incoming|Expenditure|&|||31 March|
||||||Grants|||||
||||2020|Resources|Committed||Transfers||2021|
|Designated:||||||||f|f|
|Brought fowrard|||1,688,431|830,695|(84,782)||||2,434,344|
|- Neonatal<br>Surgical|Equipment-|||||||||
|MCC 17/18|||26,799||(4,800)||||21,999|
|- Neo-Natal<br>Surgical||Unit|4,790|4,627||894|||10,311|
|- Neuro Mr Zaki|||7,578||||||7,578|
|-Ol Therapy|||2,736|||(48)|||2,688|
|-OPAT|||212||||||212|
|-Orthopaedics<br>Procedures|||15,240|772|||||16,012|
|-Outpatients|||6,850|3,114|(715)||||9,249|
|-Pain Management|||1,223|221|||||1,444|
|—PCCU (was ICU &||HDU)|40,322|9,889|(10,920)||||39,291|
|- Radiology|||2,445|19|||||2,464|
|—Renal|||4,895||||||4,895|
|-Rheumatology|||22,063|540||(18)|||22,585|
|- RMTL|||1,204||||||1,204|
|- Ryegate Bike|||20||||||20|
|- Ryegate Centre|||26,914|6,095|(2,380)||||30,629|
|- Ryegate Epilepsy|||4,160||||||4,160|
|- Ryegate Helena's|Specialist|||||||||
|Nurses|||5,194||(162)||||5,032|
|- Ryegate House|||13,604||(9,011)||||4,593|
|-Ryegate Therapy|Block||7,278|1,029|||||8,307|
|-Sleep|||72,171|2,824|||||74,995|
|-Spinal<br>Unit|||11,587|738|(435)||||11,890|
|-Theatre Admissions||Unit|463|75|||||538|
|-Theatres|||3,177|51|(1,923)||||1,305|
|- Urology|||240||||||240|
|-Ward 1 (formerly|S1)||19,113|295|||||19,408|
|-Ward 2 (formerly|S3)||24,727|1,074|||||25,801|
|-Ward 3 (formerly|M2)||3,995|1,325|||||5,320|
|-Ward 4 (formerly|M1)||675||(266)||||409|
|-Ward 5 (formerly|S2-|||||||||
|Neurosciences)|||121,626|22,779|(6,024)||||138,381|
|Sub4otal|||2,139,732|886,162|(120,590)||||2,905,304|
|Continued<br>overfeaf.|..|||||||||





## 

## 

|17.Unrestricted<br>funds|17.Unrestricted<br>funds||Balance||||Balance|
|---|---|---|---|---|---|---|---|
|(continued. ..)|||1 April|Incoming|Expenditure<br>8||31March|
||||2020<br>f|Resources<br>f|Grants Committed|Transfersf|2021f|
|Designated:||||||||
|Brought forward|||2,139,732|886,162|(120,590)||2,905,304|
|-Active Challenge|||36,996|17,402|||54,398|
|-Active Challenge<br>- Therapy<br>Rooms Artfelt Project|||20,000||||20,000|
|-Artfelt||||11,950|(87,810)|75,860||
|-Artfelt Ward 4 Project|||15,840||||15,840|
|- Safeguarding<br>Support||Unit|7,712|4,886|(54)||12,544|
|- HDU (Artfelt)|||4,303|||(4,303)||
|-Christmas|||||(1,781)|1,781||
|- Donor Recognition <br>Project|-Artfelt MIB||25,000||(24,839)|(161)||
|- EOS Scanner|||15,907||(5,000)||10,907|
|- Helipad|||27,104|8,082|||35,186|
|- Patient Entertainment<br>Hospital||Existing|9,365||||9,365|
|- Play Specialists|||1,553|95|(6,481)|4,833||
|- New Build (Artfelt)||||||||
|- New Build -Artfelt|(Glazing)||6,000||(2,413)|(2,387)|1,200|
|- New Build -Artfelt <br>cabinets)|(Museum||2,250||(2,962)|1,387|675|
|- New Build -Artfelt <br>Rooms)|(Phlebotomy||5,000||||5,000|
|- X-Ray Dept. (Artfelt)|||6,465||||6,465|
|- Building a Better <br>Make it Better)|Future (was||1,310,804|252,332|||1,563,136|
|-Research||||80|34,185||34,265|
|-Special Projects Grants|||464,527|54,869|(454,995)||64,401|
|-SPECTCT||||||||
|Total designated<br>funds|||4,098,558|1,235,858|(672,740)|77,010|4,738,686|
|Undesignated<br>funds|||384,695|1,494,312|(794,667)|(77,010)|1,007,330|
|Total unresb icted|funds-|||||||
|Charity|||4,483,253|2,730,170|1,467,40||5,746,016|
|Proiit retained<br>in subsidiary|||122,560||||13,299|
|Total unrestricted<br>Group|funds-||4,605,813||||5,759,315|





## 



## 

## 

## 

|(Acompany<br>limited by|guarantee<br>no|guarantee<br>no|t having a share capital)|t having a share capital)||||
|---|---|---|---|---|---|---|---|
|Notes tothe financial|statements||for the year ended 31||March 2021|||
|18.Restricted funds|||Balance||||Balance|
||||1 April|Incoming|||31 March|
||||2020<br>f|Resourcesf|Expendituref|Transfers|2021f|
|-Artfelt Workshops<br>National||||||||
|Foundation<br>for Youth Music|||20,312||(8,329)||11,983|
|-Artfelt Workshops<br>'Ihe Freshgate||||||||
|Trust Fund|||830||||830|
|-Artfelt Workshops<br>National||Lottery||||||
|Community<br>Fund||||9,395|(9,387)|||
|-Artfelt Workshops<br>The D'Oyly Carte||||||||
|Charitable<br>Trust||||3,500|(260)||3,240|
|-Artfelt Workshops<br>Wallace &||||||||
|Gromirs<br>Children's<br>Foundation|||6,830||||6,830|
|-Bone Research|||11,864||||11,864|
|-Building a Better Future|(Ward 6|||||||
|restricted)|||100,000|100,000|||200,000|
|-Chaplaincy|||1,168||||1,168|
|-Children's<br>Brain Disorders Research||||3,056|||3,056|
|-Community<br>Exercise Therapist||||76,061|||76,061|
|-Cystic Fibrosis (CFCF)|||73,117||||73,117|
|-Diabetes Type 1|||88|8,379|||8,467|
|- Do it For You|||168||||168|
|- Helipad|||2,419,419|5,000|||2,424,419|
|-Leukaemia<br>Research|||51,881|138|||52,019|
|-Leukaemia<br>and Oncology||||||||
|Restricted|||92,352||||92,352|
|-Build it Better||||593|||593|
|-Plastic Surgery|||175|346|||521|
|-PLRS|||53,988|1,544|||55,532|
|-Research & innowtion|||170,000||(145,328)||24,672|
|-Ryegate Centre Legacy|||10,040||||10,040|
|-Speech Therapy|||495||||495|
|-Toms Fund|||3,638||||3,638|
|-Trust Projects The True Colours||||||||
|Trust|||19,725||(15,044)||4,681|
|-Trust Projects Yorkshire|Children' s|||||||
|Hospital<br>Fund||||47,500|(47,500)|||
|-Ward 6 (Build it Better) BNA||||100,000|||100,000|
|-Ward 6 (Build it Better) Kay||Kendall||||||
|Leukaemia<br>Fund||||20,000|||20,000|
|-Ward 6 (Build it Better) Westgeld||||||||
|Health||||50,000|||50,000|
|-Ward 6Staff & Patient Support||||11,480|1,250||10,230|
||||3,036,990|436,992|227,098||3,245,984|





## 

## 

## 

## 

## 

## 

## 

## 

||||2021|2021||2021|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted||Total|
|||||5||5|
|Fixed Assets|||2,828,116|||2,828,116|
|Cash and current||investments|4,027,446|2,683,484||6,710,930|
|Current|assets||951,043|562,500||1,513,543|
|Current|liabilities||(1,719,479)|||(1,719,479)|
|Non current<br>liabilities|||(327,811)|||(327,811)|
|Total|||5,759,315|3,245,984|.|9,005,299|
||||2020|2020||2020|
||||Unrestricted|Restricted||Total|
||||8|6|||
|Fixed Assets|||2,692,450|||2,692,450|
|Cash and current||investments|2,188,676|1,911,090||4,099,766|
|Current|assets||834,793|1,125,000||1,959,793|
|Current|liabilities||(896,287)|||(896,287)|
|Non current<br>liabilities|||(213,819)|||(213,819)|
|Total|||4,605,813|3,036,090||7,641,903|





## 

## 

## 

## 

|||||2021f|2020f|
|---|---|---|---|---|---|
|The following<br>grants||have been made during the year||||
|Unrestricted<br>funds:||||||
||Medical|research projects within the Sheflield||||
||Children's|NHS FT||126,029|86,532|
||Charity<br>projects for which||there are designated|||
||funds|||623,023|706,720|
||Support|costs allocated||32,156|25,137|
|||||781,208|818,389|
|Restricted|funds:|||||
||Grants made projects for which there are restricted|||||
||funds<br>(note 18)|||227,098|46,582|
|||||1,000,306|064 011|
|All grants|made<br>in year to Shemeld||Children's<br>NHS FT|||



## 

## 

